P17 Efficacy of palliative metronomic chemotherapy: A retrospective analysis of the 15 years experience at CHU UCL Namur site Godinne

BJMO - 2021, issue 3, march 2021

Catherine Percy , Géraldine Rosier , Claire Barani , Fanny Collette , Laurence Faugeras , Lionel D'Hondt

Background: Metronomic chemotherapy consists of low-dose oral chemotherapy given continuously. The antitumor activity is supposed to be due to antiangiogenic and immunomodulation effects. This retrospective analysis was done to evaluate the benefit-risk balance of this treatment in palliative setting for unselected metastatic cancer patients.

Read more